Cronos Group Inc vs Innovative Industrial Properties Inc — how do they compare? Cronos Group Inc trades at $3.23 (market cap $1.18B), while Innovative Industrial Properties Inc trades at $51.83 (market cap $1.43B). The key difference: Innovative Industrial Properties Inc is the larger of the two by market cap, and Innovative Industrial Properties Inc pays a 14.64% dividend while Cronos Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cronos Group Inc for 22 Days and Innovative Industrial Properties Inc for 86 Days on average.
| CRON | IIPR | |
|---|---|---|
Market Cap | $1.18B | $1.43B |
Volume | 968,037 | 394,222 |
Sector | Health | Real Estate |
52-Week High | $3.55 | $64.67 |
52-Week Low | $2.30 | $44.58 |
Typical Hold Time | 22 Days | 86 Days |
Enterprise Value | $387.62M | $1.96B |
Dividend Yield | — | 14.64% |
Signals from Pluang's Aura AI — not financial advice
CRON trades at $3.22, down 0.62% on the day, amid a bearish technical signal. The stock shows mixed earnings history, with recent beats in Q1 and Q2 2026 but a miss in Q4 2025. Revenue growth is robust, increasing from $118M in 2024 to $147M in 2025, with a projected rise to $179M in 2026. However, profitability remains volatile, with a net loss of $9.45M in 2025 despite a strong gross margin of 45.86%. Recent news highlights the company's Investor Day focusing on global expansion and cash flow generation.
The outlook for CRON is cautiously optimistic, driven by international growth and a debt-free balance sheet with $827M in cash. Key risks include ongoing profitability challenges, competitive pressures, and regulatory uncertainties in the cannabis sector. Analyst sentiment is mixed, with 60% hold ratings, suggesting a wait-and-see approach. Investors should weigh strong revenue trends against execution risks and margin volatility.
IIPR trades at $51.92, up 1.35% on the day, with a bearish technical signal and oversold RSI levels. The company reported a Q2 2026 EPS beat but faces declining revenue and net income in 2025. A recent $245 million mezzanine loan commitment highlights strategic moves, while the stock offers a high dividend yield near 13%.
Outlook is mixed: deep valuation discounts and strong profitability margins present opportunity, but tenant defaults and dividend sustainability risks weigh. Analyst consensus is a Buy with a $84.67 target, suggesting significant upside if operational challenges are managed.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →Innovative Industrial Properties Inc is a real estate investment trust engaged in the acquisition, ownership, and management of specialized industrial properties leased to state-licensed operators for their regulated medical-use cannabis facilities. It conducts its business through a traditional umbrella partnership real estate investment trust, or UPREIT structure, in which properties are owned by Operating Partnership, directly or through subsidiaries. Its property portfolio is spread across the United States.
Read more on IIPR →